Skip to search.
 TSX Up 2.43% TSX Ventures Up 0.55%

XOMA Corporation (XOMA)

-NasdaqGM
0.77 Up 0.01(0.74%) Feb 12, 4:00PM EST
|After Hours : 0.80 Up 0.03 (3.45%) Feb 12, 7:56PM EST
Prev Close:0.77
Open:0.81
Bid:0.78 x 300
Ask:0.80 x 5000
1y Target Est:2.46
Beta:3.0637
Earnings Date:Mar 9 - Mar 14 (Est.)
Day's Range:0.76 - 0.82
52wk Range:0.69 - 4.93
Volume:1,931,494
Avg Vol (3m):1,957,760
Market Cap:91.88M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMAUp 0.74%91.88M
REGNUp 3.20%40.19B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.54
Quarterly EPS Est (Dec-15) :-0.15
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback